ArticleBMC cancer2023

A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors.

Satu Tiainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.